Case report
TAVI for Pure Aortic Valve Insufficiency in a Patient With a Left Ventricular Assist Device

https://doi.org/10.1016/j.athoracsur.2011.11.019Get rights and content

We report transcatheter aortic valve implantation (TAVI) for pure aortic valve insufficiency in a patient with an otherwise normal aortic valve and a long-term left ventricular assist device (LVAD). An oversized 29-mm Edwards SAPIEN valve (Edwards Lifesciences, Irvine, CA) was implanted in the 21-mm native aortic valve annulus. Despite the complete absence of aortic calcifications, the prosthesis remained stably anchored inside the annulus. The reported experience demonstrates that TAVI is feasible even in patients with pure aortic valve regurgitation and can be a reasonable option in patients with aortic regurgitation after LVAD implantation.

Section snippets

Comment

Transcatheter aortic valve implantation in patients with previously implanted LVADs has never, to our knowledge, been reported before. Additionally, TAVI in patients with pure aortic insufficiency with otherwise normal native aortic valves has never, to the best of our knowledge, been documented in the literature. TAVI in patients with pure aortic valve regurgitation and without valve calcification or degeneration is clearly contraindicated. In the absence of annular and leaflet calcifications,

References (3)

There are more references available in the full text version of this article.

Cited by (0)

View full text
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.